MX2008009818A - Combinacion coccidicida para uso veterinario. - Google Patents

Combinacion coccidicida para uso veterinario.

Info

Publication number
MX2008009818A
MX2008009818A MX2008009818A MX2008009818A MX2008009818A MX 2008009818 A MX2008009818 A MX 2008009818A MX 2008009818 A MX2008009818 A MX 2008009818A MX 2008009818 A MX2008009818 A MX 2008009818A MX 2008009818 A MX2008009818 A MX 2008009818A
Authority
MX
Mexico
Prior art keywords
combination
coccidiocide
veterinary use
veterinary compositions
coccidiocidal
Prior art date
Application number
MX2008009818A
Other languages
English (en)
Inventor
Bernardo Lozano Dubernard
Ernesto Soto Priante
Hector Salvador Sumano Lopez
Luis Ocampo Camberos
David Sarfati Mizrahi
Original Assignee
Avi Mex S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Mex S A De C V Lab filed Critical Avi Mex S A De C V Lab
Priority to MX2008009818A priority Critical patent/MX2008009818A/es
Priority to PE2011000097A priority patent/PE20110401A1/es
Priority to ES09802583.6T priority patent/ES2475266T3/es
Priority to PL09802583T priority patent/PL2319515T3/pl
Priority to EP09802583.6A priority patent/EP2319515B1/en
Priority to PCT/IB2009/006409 priority patent/WO2010013129A1/es
Priority to ARP090102918A priority patent/AR072889A1/es
Priority to BRPI0911719A priority patent/BRPI0911719A8/pt
Priority to PT98025836T priority patent/PT2319515E/pt
Priority to DK09802583.6T priority patent/DK2319515T3/da
Publication of MX2008009818A publication Critical patent/MX2008009818A/es
Priority to DO2011000030A priority patent/DOP2011000030A/es
Priority to CL2011000208A priority patent/CL2011000208A1/es
Priority to CO11023780A priority patent/CO6341549A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una combinación con efectos anticoccidiandos formada por toltrazuril y trimetoprim. También se describen composiciones veterinarias donde se utiliza dicha combinación, en donde las composiciones veterinarias tienen un efecto potenciado que hace que las aves se recuperen más rápido y tengasn menos secuelas de la enfermedad y no presentan precipitación de los ingredientes de la combinación cuando son empleadas con aguas duras.
MX2008009818A 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario. MX2008009818A (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.
PCT/IB2009/006409 WO2010013129A1 (es) 2008-07-31 2009-07-30 Combinación coccidicida para uso veterinario
ES09802583.6T ES2475266T3 (es) 2008-07-31 2009-07-30 Combinación coccidicida para uso veterinario
PL09802583T PL2319515T3 (pl) 2008-07-31 2009-07-30 Kombinacja przeciwko kokcydiom do zastosowania weterynaryjnego
EP09802583.6A EP2319515B1 (en) 2008-07-31 2009-07-30 Coccidicide combination for veterinary use
PE2011000097A PE20110401A1 (es) 2008-07-31 2009-07-30 Composicion veterinaria coccidicida que comprende toltrazuril y trimetoprim
ARP090102918A AR072889A1 (es) 2008-07-31 2009-07-30 Combinacion coccidicida para uso veterinario
BRPI0911719A BRPI0911719A8 (pt) 2008-07-31 2009-07-30 composição coccidiocida e seu uso
PT98025836T PT2319515E (pt) 2008-07-31 2009-07-30 Combinação coccidiocida para uso veterinário
DK09802583.6T DK2319515T3 (da) 2008-07-31 2009-07-30 Coccidicid kombination til veterinær anvendelse
DO2011000030A DOP2011000030A (es) 2008-07-31 2011-01-28 Combinacion coccidicida para uso veterinario
CL2011000208A CL2011000208A1 (es) 2008-07-31 2011-01-31 Combinacion coccidicida que comprende toltrazuril y trimetoprim; uso de dicha combinacion para tratar coccidiosis en aves o mamiferos.
CO11023780A CO6341549A2 (es) 2008-07-31 2011-02-28 Combinacion coccidicida para uso veterinario

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.

Publications (1)

Publication Number Publication Date
MX2008009818A true MX2008009818A (es) 2010-02-01

Family

ID=41610000

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.

Country Status (13)

Country Link
EP (1) EP2319515B1 (es)
AR (1) AR072889A1 (es)
BR (1) BRPI0911719A8 (es)
CL (1) CL2011000208A1 (es)
CO (1) CO6341549A2 (es)
DK (1) DK2319515T3 (es)
DO (1) DOP2011000030A (es)
ES (1) ES2475266T3 (es)
MX (1) MX2008009818A (es)
PE (1) PE20110401A1 (es)
PL (1) PL2319515T3 (es)
PT (1) PT2319515E (es)
WO (1) WO2010013129A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552477A (zh) * 2010-12-09 2012-07-11 天津瑞贝特科技发展有限公司 治疗鸡球虫病的中药组合物及其制备方法
ITTO20111219A1 (it) 2011-12-28 2013-06-29 Beta Renewables Spa Procedimento migliorato di pre-impregnazione per la conversione di biomassa
WO2016181187A1 (es) * 2015-05-11 2016-11-17 Laboratorio Avi-Mex, S.A. De C.V. Composición para el tratamiento de parasitosis por gregarinas en camarones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454859B (sv) 1983-11-16 1988-06-06 Stig Olofsson Platta
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten

Also Published As

Publication number Publication date
PE20110401A1 (es) 2011-07-24
BRPI0911719A2 (pt) 2015-10-06
WO2010013129A1 (es) 2010-02-04
EP2319515A1 (en) 2011-05-11
PL2319515T3 (pl) 2014-10-31
ES2475266T3 (es) 2014-07-10
EP2319515B1 (en) 2014-05-07
PT2319515E (pt) 2014-05-27
AR072889A1 (es) 2010-09-29
CL2011000208A1 (es) 2011-05-06
BRPI0911719A8 (pt) 2018-03-06
CO6341549A2 (es) 2011-11-21
DK2319515T3 (da) 2014-06-30
EP2319515A4 (en) 2011-12-21
DOP2011000030A (es) 2011-04-15

Similar Documents

Publication Publication Date Title
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
MX2009013810A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos.
MX2010005346A (es) Composiciones farmaceuticas.
PH12012501522A1 (en) Oral care compositions
PH12012501620A1 (en) Oral care compositions
CL2012000096A1 (es) Uso de alfa-pineno y cinamaldehido en composicion de alimentos que sirve para mejorar tasa de convension en animales acuaticos; composicion de alimentos; y aditivo que contienen alfa-pineno y cinamaldehido como ingredientes principales.
MX342833B (es) Composiciones de cuidado oral acuosas.
MX346335B (es) Composiciones antisentido, y metodos para obtener y usar las mismas.
BR112015015898A8 (pt) composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
EP2316412A3 (en) High-clarity aqueous concentrates of 4-hexylresorcinol
MX355284B (es) Composiciones para cuidado oral que comprenden carbonato de calcio y arcilla.
MY159492A (en) Solid pharmaceutical formulation with delayed release
PH12012500754A1 (en) Pharmaceutical composition comprising oligopeptides
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
WO2011104652A3 (en) Veterinary compositions
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
PH12013500223A1 (en) Oral care product and methods of use and manufacture thereof
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
PH12014501264A1 (en) Oral care compositions
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
PH12012501389A1 (en) Hedgehog inhibitors
WO2009022670A1 (ja) 速崩壊性錠剤
BR112015019776A2 (pt) comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos
MA33022B1 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil
PH12013500371A1 (en) Therapeutic agent for pain

Legal Events

Date Code Title Description
FG Grant or registration